Cosmecca Korea Expands Control Over Englewood Lab to Accelerate North American Market Strategy

From 50% to a Maximum of 66.7%: Tender Offer at 13,000 Won per Share
Enhancing Global ODM Competitiveness by Strengthening North American Execution

On March 3, Cosmecca Korea, a global cosmetics OGM (Global Standard Manufacturing) specialist, announced that it will pursue a tender offer for its U.S. subsidiary, Englewood Lab. The company stated that the tender offer will be funded with its own resources and will be conducted within the scope of maintaining financial soundness.

Englewood Lab is a cosmetics ODM company that has secured global indie brands as clients based on its local production facilities and research and development (R&D) capabilities in the United States. Among Korean ODM (Original Design Manufacturer) companies, it is recognized as a case that has successfully established a local production and development system in North America and achieved tangible results.

Exterior view of Cosmecca Korea Central Research Institute. Cosmecca Korea

Cosmecca Korea currently holds a 50% stake in Englewood Lab and plans to increase its ownership to a maximum of 66.7% through this tender offer. The strategy is to strengthen control, further advance the decision-making system, and enhance business execution capabilities in North America.

The tender offer targets 3,311,310 common shares of Englewood Lab, and the offer period is 21 days, from March 3 to March 23, 2026. The tender offer price is 13,000 won per share.

Cosmecca Korea plans to use the increase in its stake as an opportunity to strengthen its 'Made in USA' production capabilities and to integrate Korea-U.S. technology collaboration and product development processes. The company also aims to improve operational efficiency by unifying ERP systems between the two legal entities, as well as to enhance cost structure and strengthen the connection between production and sales networks.

Recently, as the global cosmetics market has shifted to focus on functional skincare, clean beauty, and indie brands, the importance of local responsiveness has increased. The company plans to strengthen its collaboration with Englewood Lab to improve its competitiveness in the North American market and to expand its profit base.

A Cosmecca Korea official stated, "This tender offer is a measure to improve the operational efficiency of our North American business and to stabilize the structure for generating results," adding, "It is a practical step toward achieving consolidated sales of 1 trillion won in the mid-to-long term. Based on our two major production hubs in Korea and the United States, we will continue to strengthen our competitiveness in the global cosmetics ODM market."

Meanwhile, Cosmecca Korea previously increased its stake in Englewood Lab from 39% to 50% through a tender offer in February 2025.

This content was produced with the assistance of AI translation services.